SEC Form SC 13G/A filed by Aurora Cannabis Inc. (Amendment)

$ACB
Medicinal Chemicals and Botanical Products
Health Care
Get the next $ACB alert in real time by email
SC 13G/A 1 ea155666-sc13ga3etf_aurora.htm AMENDMENT NO. 3 TO SCHEDULE 13G

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934

 

(Amendment No. 3)*

 

Aurora Cannabis Inc

(Name of Issuer)

 

Common Stock, $0.001 Par Value Per Share

(Title of Class of Securities)

 

05156X884

(CUSIP Number)

 

February 11, 2022

(Date of Event which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)

 

Rule 13d-1(c)

 

Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

SCHEDULE 13G

 

CUSIP No. 05156X884

 

1 Names of Reporting Persons
ETF Managers Group LLC
2 Check the appropriate box if a member of a Group (see instructions)
(a)  ☐
(b)  ☒ See Item of attached schedule
3 Sec Use Only
4 Citizenship or Place of Organization
Delaware

Number of
Shares
Beneficially
Owned by Each
Reporting Person
With:

 

5 Sole Voting Power
9,642,277
6 Shared Voting Power
 
7 Sole Dispositive Power
9,642,277
8 Shared Dispositive Power
 

9 Aggregate Amount Beneficially Owned by Each Reporting Person
9,642,277
10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11 Percent of class represented by amount in row (9)
4.86%
12 Type of Reporting Person (See Instructions)
IA

 

Page 2 of 5

 

  

Item 1.

 

(a)Name of Issuer: Aurora Cannabis Inc.

 

(b)Address of Issuer’s Principal Executive Offices: 10355 Jasper Avenue Suite 500, Edmonton, AB T5J 1Y6, Canada

 

Item 2.

 

(a)Name of Person Filing: ETF Managers Group LLC

 

(b)Address of Principal Business Office or, if None, Residence:

 

ETF Managers Group LLC - 30 Maple Street, Suite 2, Summit, New Jersey 07091

 

(c)Citizenship: ETF Managers Group LLC – Delaware

 

(d)Title and Class of Securities: Common Stock

 

(e)CUSIP No.: 05156X884

 

Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

  (a) Broker or dealer registered under Section 15 of the Act;

 

  (b) Bank as defined in Section 3(a)(6) of the Act;

 

  (c) Insurance company as defined in Section 3(a)(19) of the Act;

 

  (d) Investment company registered under Section 8 of the Investment Company Act of 1940;

 

  (e) An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

  (f) An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

 

  (g) A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

 

  (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 

  (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;

 

  (j) A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

 

  (k) Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

  

Page 3 of 5

 

 

Item 4.Ownership

 

(a)Amount Beneficially Owned: 9,642,277

 

(b)Percent of Class: 4.86%

 

(c)Number of shares as to which such person(s) has:

 

(i)Sole power to vote or to direct the vote:   9,642,277

 

(ii)Shared power to vote or to direct the vote:

 

(iii)Sole power to dispose or to direct the disposition of:   9,642,277

 

(iv)Shared power to dispose or to direct the disposition of:

 

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

 

Item 6.Ownership of more than Five Percent on Behalf of Another Person.

 

Not Applicable

 

Item 7.Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

 

Not Applicable

 

Item 8.Identification and classification of members of the group.

 

Not Applicable.

 

Item 9.Notice of Dissolution of Group.

 

Not Applicable

 

Item 10.Certifications.

 

By signing below, we certify that, to the best of our knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 4 of 5

 

 

SIGNATURE

 

After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.

 

Dated:  February 14, 2022

 

/s/ Reshma A. Tanczos  
Name/Title: Reshma A. Tanczos,  
Chief Compliance Officer,  
ETF Managers Group LLC  

 

 

Page 5 of 5

 

 

Get the next $ACB alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ACB

DatePrice TargetRatingAnalyst
12/11/2024Buy
TD Cowen
2/9/2024Hold → Buy
Canaccord Genuity
9/21/2022Sell → Hold
Canaccord Genuity
6/24/2022Neutral → Overweight
Cantor Fitzgerald
6/6/2022Sell → Hold
Stifel
11/10/2021$9.60 → $10.75Neutral
Cantor Fitzgerald
10/28/2021$9.50 → $9.60Neutral
Cantor Fitzgerald
10/5/2021$8.30 → $9.50Neutral
Cantor Fitzgerald
More analyst ratings

$ACB
Press Releases

Fastest customizable press release news feed in the world

See more
  • Aurora Cannabis Recognized for Executive Gender Diversity by The Globe and Mail

    Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB, March 31, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level. "As a company with a leading purpose of bein

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis to Speak at the Global Cannabis Regulatory Summit

    NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. EDMONTON, AB, March 25, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. on March 26-27, 2025. "The opportunity to speak on this global stage, underscores our position as industry leaders and d

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Breakthrough Discovery of Powdery Mildew Resistant Cultivars

    NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launc

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$ACB
SEC Filings

See more

$ACB
Leadership Updates

Live Leadership Updates

See more
  • Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

    NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executiv

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

    NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /PRNewswire/ -  Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Appointment of New Director

     NASDAQ | TSX: ACB  Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB, May 15, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today. Mr. Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governance. His impressive career is characterized by executive level roles with leadin

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Financials

Live finance-specific insights

See more
  • Aurora Cannabis Announces Fiscal 2025 Third Quarter Results

    NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis to Host Third Quarter 2025 Investor Conference Call

    NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer,

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care
  • Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

    NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210%Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical CannabisRe-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2EDMONTON, AB, Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.

    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

$ACB
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more